摘要
众所周知,骨髓间质干细胞(MSCs)可帮助治疗组织损伤,常被称为流动性细胞。然而,MSCs也在癌细胞中出现从而对肿瘤生长和发展期产生相似的帮助。本综述描述了癌症发展和转移期的一些重要步骤,其中包括MSCs参与且可能起重要作用的各步。MSCs能提高癌细胞回避免疫攻击的能力,同时促进肿瘤血管生成,甚至对化疗和其他抗癌药产生反作用。此外,MSCs参与癌细胞侵袭和转移的多个关键步骤,其中包括刺激上皮-间质转化和诱导干细胞样性质,这种性质可使癌症干细胞在血循环中增加存活率。将对这些步骤进行详细描述。本文讨论了循环肿瘤细胞(CTCs)和肿瘤干细胞(CSCs)的不同之处,同时描述了转移前微环境的形成,即来自于癌细胞和转移期和肿瘤延续期的MSCs的外来体角色。越来越多的人提出将MSCs作为很有前途的肿瘤靶向给药工具。为了达到这一期望,对于MSCs在癌症转移进程中起的确切作用必须有更深层的理解,以期创建一些补救措施来提高现有疗法的疗效。
关键词: 癌症转移期,肿瘤干细胞,循环肿瘤细胞,外来体,间质干细胞,微环境。
图形摘要
Current Cancer Drug Targets
Title:Involvement of Mesenchymal Stem Cells in Cancer Progression and Metastases
Volume: 15 Issue: 2
Author(s): Astra I. Chang, Aaron H. Schwertschkow, Jan A. Nolta and Jian Wu
Affiliation:
关键词: 癌症转移期,肿瘤干细胞,循环肿瘤细胞,外来体,间质干细胞,微环境。
摘要: Mesenchymal stem/stromal cells (MSCs) are known to be the helpers for the healing of tissue damage, often referred to as ambulatory cells. However, MSCs are also recruited by cancer cells to similarly aid in tumor growth and progression. In this review, some of the key steps in cancer progression and metastases are described including the various steps in which MSCs participate and may play important roles. MSCs aid in cancer cells’ ability to evade immune attack, while promoting tumor angiogenesis, even being counter-acting against chemotherapeutics and other drugs used to fight various cancers. Furthermore, MSCs participate in many of the crucial steps in invasion and metastasis, including stimulating the epithelial-mesenchymal transition (EMT) and induction of stem-like properties that allow cancer stem cells to increase their survivability through the circulation. These steps are described in detail. Differences between circulating tumor cells (CTCs) and cancer stem cells (CSCs) are discussed, along with descriptions of the formation of a pre-metastatic niche, the role of exosomes from both cancer cells and MSCs in metastasis and tumor reseeding (self-seeding). More and more, MSCs are being proposed as a promising tumor targeting drug-delivery tool. In order to fulfill this promise, further understanding of the precise roles that MSCs play in the process of cancer metastases must be achieved, in attempting to create remedies that will improve the outcome of available therapeutics.
Export Options
About this article
Cite this article as:
Astra I. Chang, Aaron H. Schwertschkow, Jan A. Nolta and Jian Wu , Involvement of Mesenchymal Stem Cells in Cancer Progression and Metastases, Current Cancer Drug Targets 2015; 15 (2) . https://dx.doi.org/10.2174/1568009615666150126154151
DOI https://dx.doi.org/10.2174/1568009615666150126154151 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of the APP Non-Amyloidogenic Signaling Pathway and Targeting α-Secretase as an Alternative Drug Target for Treatment of Alzheimers Disease
Current Medicinal Chemistry Scorpion Toxin Polyptides as Therapeutic Agents: An Overview
Protein & Peptide Letters PPARγ and Its Ligands: Potential Antitumor Agents in the Digestive System
Current Stem Cell Research & Therapy Developments of Polo-like Kinase 1 (Plk1) Inhibitors as Anti-Cancer Agents
Mini-Reviews in Medicinal Chemistry Anticancer Activity of Organogallium(III) Complexes in Colon Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Passive Targeting of Cyclophosphamide-Loaded Carbonate Apatite Nanoparticles to Liver Impedes Breast Tumor Growth in a Syngeneic Model
Current Pharmaceutical Design The Use of Therapeutic Peptides to Target and to Kill Cancer Cells
Current Medicinal Chemistry Cell Bystander Effect Induced by Radiofrequency Electromagnetic Fields and Magnetic Nanoparticles
Current Nanoscience Viral Vectors in Cancer Immunotherapy: Which Vector for Which Strategy?
Current Gene Therapy Microenvironmental Determinants of Adult Neural Stem Cell Proliferation and Lineage Commitment in the Healthy and Injured Central Nervous System
Current Stem Cell Research & Therapy HR-MAS NMR Spectroscopy: A Practical Guide for Natural Samples
Current Organic Chemistry The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells
Current Drug Targets Cucurbitacin E, An Experimental Lead Triterpenoid with Anticancer, Immunomodulatory and Novel Effects Against Degenerative Diseases. A Mini-Review
Current Topics in Medicinal Chemistry Therapeutic Potential of Curcumin in the Treatment of Glioblastoma Multiforme
Current Pharmaceutical Design Anticancer Agents Derived from Natural Cinnamic Acids
Anti-Cancer Agents in Medicinal Chemistry Implications of Epigenetic Mechanisms and their Targets in Cerebral Ischemia Models
Current Neuropharmacology Matrix Metalloproteinases: Drug Targets for Myocardial Infarction
Current Drug Targets Delivery Methods of Camptothecin and Its Hydrosoluble Analogue Irinotecan for Treatment of Colorectal Cancer
Current Drug Delivery The Application of Stimuli-responsive Nanocarriers for Targeted Drug Delivery
Current Topics in Medicinal Chemistry Chalcones as Promising Lead Compounds on Cancer Therapy
Current Medicinal Chemistry